Non-AIDS In-Hospital Deaths Up in HIV-Infected Patients

This article originally appeared here.
Share this content:
Non-AIDS In-Hospital Deaths Up in HIV-Infected Patients
Non-AIDS In-Hospital Deaths Up in HIV-Infected Patients

WEDNESDAY, July 8, 2015 (HealthDay News) -- Trends in hospital deaths among HIV-infected patients show that mortality during the antiretroviral therapy (ART) era is often caused by diseases and conditions other than AIDS. The findings were published online June 30 in the Journal of Hospital Medicine.

Annie Cowell, M.D., of the University of California in San Diego, and colleagues reviewed the medical records of HIV-infected patients who died at an urban teaching hospital from 1995 through 2011. The authors sought to assess causes of death and factors associated with mortality.

The researchers found that in-hospital deaths among HIV-infected patients declined significantly, and deaths that were not attributable to AIDS increased from 43.0 to 70.5 percent. The most common causes of non-AIDS deaths were non-AIDS infection (20.3 percent), cardiovascular conditions (11.3 percent), liver disease (8.5 percent), and non-AIDS malignancy (7.8 percent). Patient factors significantly associated with non-AIDS deaths versus AIDS-related deaths included older age (median age, 48 versus 40 years), more likely to be on ART (74.1 versus 55.8 percent), less likely to have a CD4 count of <200 cells/mm³ (47.2 versus 97.1 percent), and more likely to have an HIV viral load of ≤400 copies/mL (38.1 versus 4.1 percent).

"Physicians caring for hospitalized patients should appreciate the current trends in the HIV epidemic to provide comprehensive and appropriate interventions that can reduce mortality for HIV-infected inpatients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths